Cannabis Investors: 2 Pot Stocks That Will Be Profitable in 2020

Cannabis investors have witnessed a strong correction this year. Is it time to play safe and bet on profitable pot stocks in an uncertain macro-environment?

| More on:
Marijuana plant and cannabis oil bottles isolated

Image source: Getty Images

After an underwhelming 2019, cannabis investors will be hoping the sun shines bright on pot stocks next year. We have seen the absolute decimation of several cannabis stocks in 2019.

The stocks in the pot industry have been impacted by valuation concerns, lower-than-estimated growth, slow rollout of retail stores, high inventory levels, regulatory concerns, vaping scandals, and competition from the illegal market in 2019.

We can understand why investors turned bearish so quickly after the legalization of recreational cannabis in Canada drove stocks to record highs in October 2018. However, with several pot stocks losing close to 70% in market value, is it safe to assume that the worst is over?

I’ll look at two cannabis stocks that will soon be profitable.

Aphria will end fiscal 2020 with an EBITDA of $594 million

Shares of Aphria (TSX:APHA)(NYSE:APHA) are trading at $6.94, which is 65% below its record high. Despite its steep fall since January 2018, APHA stock has returned close to 800% since its IPO in December 2014.

While most pot stocks are struggling with expanding losses, Aphria has already been profitable in the last two quarters. Driven by the strong domestic demand, the company has managed to increase sales from $20.4 million in fiscal 2017 (year ended in May) to $36.9 million in 2018 and $237 million in 2019.

Analysts now expect sales to reach $594 million in 2020, $790 million in 2021, and $922 million in 2022. This growth in sales will also boost APHA’s bottom line. After posting a negative EBITDA of -$27.7 million, this metric is forecast to rise to $42.5 million in 2020, indicating a margin of 7.2%.

Aphria’s EBITDA is estimated to reach $197 million by 2022, indicating a margin of 21.4%. A positive bottom line suggests that Aphria stock is trading at a forward price-to-earnings multiple of 26.

The stock is valued at $1.65 billion in terms of market cap or just 2.8 times forward sales. With a price-to-book value of 0.95, Aphria is one of the cheapest pot stocks to own right now. The company continues to invest in expanding production facilities. It now produces 255,000 kg annually.

OrganiGram has lost 40% in 2019

Shares of OrganiGram Holdings (TSXV:OGI)(NASDAQ:OGI) are trading at $3.36, which is 70% below its record high of $11.72. OGI stock was publicly listed in January 2012 and has returned 1,070% since then.

OGI was one of the few companies to beat consensus revenue estimates in the last reported quarter. Despite its encouraging results, OGI is struggling to make a comeback due to the overall weakness in the pot industry.

In fiscal 2020 (ending in August), analysts have forecast sales of $134 million, up 67% year over year. Sales are then estimated to reach $226 million in 2021 and $263 million in 2022. Similar to Aphria, OGI also ended 2019, with a positive EBITDA of $19.9 million, indicating a margin of 25%.

By the end of 2022, the company’s EBITDA is forecast reach $78.1 million, which will mean a margin of 29.7%. A positive bottom line suggests that OGI stock is trading at a forward price-to-earnings multiple of 19.9. The stock is valued at $528 million in terms of market cap 6.6 times forward sales.

The growth story for pot stocks remains intact. The slow rollout of retail stores will impact these companies in the short term. However long-term investors can experience stellar returns given the industry’s expanding addressable market.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

The Motley Fool recommends OrganiGram Holdings and OrganiGram Holdings. Fool contributor Aditya Raghunath has no position in any of the stocks mentioned.

More on Cannabis Stocks

Worker tags plants at an industrial cannabis operation
Cannabis Stocks

Can Canopy Growth Stock Finally Recover in 2024?

Down 98% from all-time highs, Canopy Growth remains a high-risk investment in 2024 given its weak fundamentals.

Read more »

A close up image of Canadian $20 Dollar bills
Tech Stocks

3 No-Brainer Stocks to Buy With $20 Right Now

These three stocks are easy buys for those who don't have all that much to spend, and want long-term growth…

Read more »

Pot stocks are a riskier investment
Cannabis Stocks

Slow Burn: Is Aurora Cannabis Finally a Good Buy in June?

One of the benefits of choosing from some of the most beaten-down market segments like cannabis is that even a…

Read more »

Caution, careful
Cannabis Stocks

I Wouldn’t Touch This TSX Stock With a 60-Foot Pole

I wouldn't touch Canopy Growth Corp (TSX:WEED) stock with a 60-foot pole.

Read more »

edit Cannabis leaves of a plant on a dark background
Cannabis Stocks

Why This Little-Known Cannabis Stock Could Double in 2024

This cannabis stock has already doubled this year since 52-week lows and could easily rise that much once more.

Read more »

Bad apple with good apples
Cannabis Stocks

1 TSX Stock I Wouldn’t Touch With a 420-Foot Pole

Down 87% from all-time highs, Cronos Group stock is a still a high-risk investment for long-term shareholders in 2024.

Read more »

A cannabis plant grows.
Cannabis Stocks

Canopy Growth: Buy, Sell, or Hold?

Canopy Growth (TSX:WEED) stock should make a killing on U.S. expansion, but investors will need to be very patient.

Read more »

Marijuana plant and cannabis oil bottles isolated
Energy Stocks

3 Canadian Value Stocks to Buy Right Now

Undervalued Canadian stocks such as Secure Energy should be part of your shopping list in May 2024.

Read more »